newsfilter
← Latest News
GlobeNewswire·

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2022 and Recent Developments

-- Recorded Third Quarter Revenue of $31.5 Million -- -- Myford South and Viral Vector Facilities Construction Continues On Schedule -- -- Signed $52 Million in Net New Business Orders and Ended the Quarter with a Backlog of $140 Million; Highest